18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. (Q45915234)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2009

Language	Label	Description	Also known as
English	18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.	scientific article published in November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

1 reference

based on heuristic

inferred from title

author name string

Jean-Louis Alberini

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Florence Lerebours

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Myriam Wartski

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Emmanuelle Fourme

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Elise Le Stanc

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

E Gontier

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

O Madar

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

P Cherel

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

A P Pecking

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

115

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

21

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

5038-5047

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

21 January 2018

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on the management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast carcinoma: pathological or clinical entity?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

F-18 FDG uptake in breast infection and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the clinical diagnosis of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory breast cancer: clinical progress and the main problems that must be addressed

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving role of imaging modalities in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24534

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24534

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19645022

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45915234&oldid=1514287211"